SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-095653
Filing Date
2020-08-14
Accepted
2020-08-14 17:15:42
Documents
41
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020540-1_10q.htm 10-Q 344567
2 EXHIBIT 10.1 tm2020540d1_ex10-1.htm EX-10.1 99782
3 EXHIBIT 31.1 tm2020540d1_ex31-1.htm EX-31.1 9627
4 EXHIBIT 31.2 tm2020540d1_ex31-2.htm EX-31.2 9592
5 EXHIBIT 32.1 tm2020540d1_ex32-1.htm EX-32.1 3895
6 EXHIBIT 32.2 tm2020540d1_ex32-2.htm EX-32.2 3680
  Complete submission text file 0001104659-20-095653.txt   1860774

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT atxi-20200630.xml EX-101.INS 299691
8 XBRL TAXONOMY EXTENSION SCHEMA atxi-20200630.xsd EX-101.SCH 18382
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20200630_cal.xml EX-101.CAL 19212
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20200630_def.xml EX-101.DEF 74925
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20200630_lab.xml EX-101.LAB 152625
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20200630_pre.xml EX-101.PRE 135274
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 201106576
SIC: 2834 Pharmaceutical Preparations